The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Missed Opportunities: Racial Disparities in Adjuvant Breast Cancer Treatment
Abstract
Purpose: Underuse of adjuvant therapy is a potentially important and remediable explanation for the inferior survival of minority women with breast cancer. We sought to measure a racial disparity in the underuse of adjuvant treatments for early-stage breast cancer and to identify associated factors. Methods: Cross-sectional study with review of all inpatient and outpatient medical records of 677 women treated surgically for a primary American Joint Committee on Cancer stage I or II breast cancer in 1999 to 2000. Underuse was defined as omissions of radiation therapy after breast-conserving surgery, adjuvant chemotherapy after resection of hormone-receptor-negative tumors ≥ 1 cm, or hormonal therapy for receptor-positive tumors ≥ 1 cm. Results: One hundred forty-five (21%) of 677 women experienced underuse of appropriate adjuvant therapy: 16% in whites, 34% in blacks, and 23% in Hispanics (P < .001). Women referred to medical oncologists were less likely to experience underuse of necessary adjuvant treatments (relative risk [RR] for underuse = 0.2; 95% CI, 0.1 to 0.3). Women who were minorities (RR = 2.0; 95% CI, 1.3 to 3.1), had higher levels of comorbidity (RR = 1.4; 95% CI, 1.1 to 1.8) and lacked insurance (RR = 1.9; 95% CI, 0.9 to 4.0) were at greater risk for underuse. Conclusion: Minority women with early-stage breast cancer have double the risk of white women for failing to receive necessary adjuvant treatments despite rates of oncologic consultation similar to those for white women. Oncology referrals are necessary to reduce treatment disparities but are not sufficient to ensure patients' receipt of efficacious adjuvant treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Racial and Ethnic Disparities in the Receipt of Cancer Treatment
Shavers, V. L. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.5.334 · Cited by 950
Effect of Age and Comorbidity in Postmenopausal Breast Cancer Patients Aged 55 Years and Older
Yancik, R. (2001) · JAMA · doi:10.1001/jama.285.7.885 · Cited by 896
(2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.13.979 · Cited by 893
Weir, H. K. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg040 · Cited by 867
Treatment of Early-Stage Breast Cancer
(1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460030097037 · Cited by 782
Differences in Breast Cancer Stage, Treatment, and Survival by Race and Ethnicity
Li, C. I., Malone, K. E., & Daling, J. R. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.1.49 · Cited by 662
Eley, J. W. (1994) · JAMA · doi:10.1001/jama.1994.03520120057031 · Cited by 531
山口, 博. (2006) · Mebio oncology · Cited by 516
Survival of Blacks and Whites After a Cancer Diagnosis
Bach, P. B. (2002) · JAMA · doi:10.1001/jama.287.16.2106 · Cited by 513
Comorbidity and Survival Disparities Among Black and White Patients With Breast Cancer
Tammemagi, C. M. (2005) · JAMA · doi:10.1001/jama.294.14.1765 · Cited by 432
Shavers, V. L., Harlan, L. C., & Stevens, J. L. (2003) · Cancer · doi:10.1002/cncr.11051 · Cited by 311
Racial Differences in Survival From Breast Cancer
Joslyn, S. A. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520370040031 · Cited by 216
Disparities across the breast cancer continuum
Bigby, J., & Holmes, M. D. (2005) · Cancer Causes & Control · doi:10.1007/s10552-004-1263-1 · Cited by 191
Racial Disparity in the Dose and Dose Intensity of Breast Cancer Adjuvant Chemotherapy
Griggs, J. J., Sorbero, M. E. S., Stark, A. T., Heininger, S. E., & Dick, A. W. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1025481505537 · Cited by 185
Panel, N. I. O. H. C. D. (2001) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a003460 · Cited by 153
Variations in breast carcinoma treatment in older medicare beneficiaries: Is it black and white?
Mandelblatt, J. S., Kerner, J. F., Hadley, J., Hwang, Y., Eggert, L., Johnson, L., & Gold, K. F. (2002) · Cancer · doi:10.1002/cncr.10825 · Cited by 151
Chu, K. C., Lamar, C. A., & Freeman, H. P. (2003) · Cancer · doi:10.1002/cncr.11411 · Cited by 144
Moormeier, J. A. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-10-199605150-00007 · Cited by 144
Racial differences in treatment and survival from early‐stage breast carcinoma
Joslyn, S. A. (2002) · Cancer · doi:10.1002/cncr.10827 · Cited by 129
NCCN Practice Guidelines for Breast Cancer.
Carlson, R. W., Anderson, B. O., Bensinger, W., Cox, C. E., Davidson, N. E., Edge, S. B., Farrar, W. B., Goldstein, L. J., Gradishar, W., Lichter, A. S., et al. (2000) · PubMed · Cited by 110
Quality of Breast Cancer Care: What Do We Know?
Malin, J. L., Schuster, M. A., Kahn, K. L., & Brook, R. H. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.04.020 · Cited by 96
Determining the Quality of Breast Cancer Care: Do Tumor Registries Measure Up?
Bickell, N. A., & Chassin, M. R. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-9-200005020-00004 · Cited by 95
Self-citationPhysicians’ Reasons for Failing to Deliver Effective Breast Cancer Care
Bickell, N. A., & McEvoy, M. D. (2003) · Medical Care · doi:10.1097/01.mlr.0000052978.49993.27 · Cited by 64
Self-citationCommunity-based Assessment of Adjuvant Hormone Therapy in Women with Breast Cancer, 1991-1997
Du, X. L., Key, C. R., & Osborne, C. (2004) · The Breast Journal · doi:10.1111/j.1075-122x.2004.21357.x · Cited by 8
Cited by
Burstein, H. J., Prestrud, A. A., Seidenfeld, J., Anderson, H., Buchholz, T. A., Davidson, N. E., Gelmon, K. E., Giordano, S. H., Hudis, C. A., Malin, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3756 · Cited by 796
DeSantis, C. E., Siegel, R. L., Sauer, A. G., Miller, K. D., Fedewa, S. A., Alcaraz, K. I., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21340 · Cited by 790
Morris, G. J., Naidu, S., Topham, A. K., Guiles, F., Xu, Y., McCue, P., Schwartz, G. F., Park, P. K., Rosenberg, A. L., Brill, K., et al. (2007) · Cancer · doi:10.1002/cncr.22836 · Cited by 602
Annual report to the nation on the status of cancer, part 1: National cancer statistics
Cronin, K. A., Scott, S., Firth, A. U., Sung, H., Henley, S. J., Sherman, R. L., Siegel, R. L., Anderson, R. N., Kohler, B. A., Benard, V. B., et al. (2022) · Cancer · doi:10.1002/cncr.34479 · Cited by 557
Health and Racial Disparity in Breast Cancer
Yedjou, C. G., Sims, J. N., Miele, L., Noubissi, F., Lowe, L., Fonseca, D. D., Alo, R. A., Payton, M., & Tchounwou, P. B. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-20301-6_3 · Cited by 509
Metadata
- Authors
- Bickell, N. A., Wang, J. J., Oluwole, S., Schrag, D., Godfrey, H., Hiotis, K., Mendez, J., & Guth, A. A.
- Venue
- Journal of Clinical Oncology
- Published
- 2006-03-20
- Volume
- 24
- Issue
- 9
- Pages
- 1357-1362
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2164669790
- Cited by
- 363
- References
- 27
- FWCI
- 8.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.